小分子
组合化学
合成生物学
计算机科学
纳米技术
化学生物学
化学合成
药物发现
化学
计算生物学
材料科学
生物
生物化学
体外
作者
Nathan Collins,David Stout,Jin-Ping Lim,Jeremiah P. Malerich,Nagi N. Mansour,Peter B. Madrid,Mario Latendresse,David Krieger,Judy Szeto,Vi-Anh Vu,Kristina Rucker,Michael DeLeo,Y. Gorfu,Markus Krummenacker,Leslie A. Hokama,Peter D. Karp,Sahana Mallya
标识
DOI:10.1021/acs.oprd.0c00143
摘要
Automated peptide and oligonucleotide synthesizers enabled a revolution in molecular biology and helped pave the way to modern synthetic biology. Similarly, fully automated synthetic chemistry could herald a new wave of innovation in biology and materials sciences by greatly facilitating access to known and novel molecules. Here, we report on an automated multistep chemical synthesizer, AutoSyn, that makes milligram-to-gram-scale amounts of virtually any drug-like small molecule in a matter of hours and demonstrate its versatility with the synthesis of ten known drugs. Of the FDA-approved small-molecule drugs for which we were able to compute a synthetic route, 87% are predicted to be synthesizable on AutoSyn. Moreover, AutoSyn enables digital synthesis protocols that ensure the reproducibility and transferability of synthesis protocols from one lab to another.
科研通智能强力驱动
Strongly Powered by AbleSci AI